Generation Bio Co.

General ticker "GBIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $127.5M (TTM average)

Generation Bio Co. does not follow the US Stock Market performance with the rate: -8.9%.

Estimated limits based on current volatility of 6.2%: low 0.35$, high 0.40$

Factors to consider:

  • Earnings expected soon, date: 2025-05-12 bmo
  • Current price 54.3% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.79$, 3.07$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.55$, 4.75$]

Financial Metrics affecting the GBIO estimates:

  • Negative: Non-GAAP EPS, $ of -1.98 <= 0.04
  • Negative: Operating cash flow per share per price, % of -51.67 <= 1.79
  • Negative: negative Operating income
  • Positive: 22.52 < Shareholder equity ratio, % of 37.29 <= 43.26
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Inventory ratio change, % of 33.91 > 1.05
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term GBIO quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-090.320.340.360.380.40.420.440.46
Price $

Long-term GBIO plot with estimates

01234567Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
GBIOS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $5.90MM $19.89MM
Operating Expenses $141.18MM $144.47MM $162.28MM
Operating Income $-141.18MM $-138.56MM $-142.39MM
Non-Operating Income $4.54MM $11.95MM $10.72MM
R&D Expense $96.72MM $93.62MM $61.30MM
Income(Loss) $-136.64MM $-126.61MM $-131.67MM
Profit(Loss)* $-132.10MM $-126.61MM $-131.67MM
Stockholders Equity $282.49MM $203.13MM $86.20MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $376.26MM $374.76MM $231.20MM
Operating Cash Flow $-102.45MM $-52.74MM $-88.56MM
Capital expenditure $8.80MM $7.40MM $2.40MM
Investing Cash Flow $-192.51MM $-9.70MM $94.53MM
Financing Cash Flow $12.99MM $35.82MM $0.25MM
Earnings Per Share** $-2.27 $-1.96 $-1.98

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.